AAAAAA

   
Results: 1-25 | 26-36
Results: 1-25/36
DIAMINIC CARBONATES, A NEW CLASS OF ANTIINFLAMMATORY COMPOUNDS - THEIR BIOLOGICAL CHARACTERIZATION AND MODE OF ACTION
Authors: PORRO G BERTOLINI G BONARDI MA GIOVANETTI E LENTO P LEONI F MODENA D PAVICH G MARCUCCI F
Citation: G. Porro et al., DIAMINIC CARBONATES, A NEW CLASS OF ANTIINFLAMMATORY COMPOUNDS - THEIR BIOLOGICAL CHARACTERIZATION AND MODE OF ACTION, The Journal of pharmacology and experimental therapeutics, 285(1), 1998, pp. 193-200
COEXPRESSION OF ERYTHROID AND MEGAKARYOCYTIC GENES IN ACUTE ERYTHROBLASTIC (FAB M6) AND MEGAKARYOBLASTIC (FAB M7) LEUKEMIAS
Authors: LINARI S VANNUCCHI AM CIOLLI S LEONI F CAPORALE R GROSSI A PAGLIAI G SANTINI V PAOLETTI F FERRINI PR
Citation: S. Linari et al., COEXPRESSION OF ERYTHROID AND MEGAKARYOCYTIC GENES IN ACUTE ERYTHROBLASTIC (FAB M6) AND MEGAKARYOBLASTIC (FAB M7) LEUKEMIAS, British Journal of Haematology, 102(5), 1998, pp. 1335-1337
INTERLEUKIN-2 THERAPY IN RELAPSED ACUTE MYELOGENOUS LEUKEMIA
Authors: MELONI G VIGNETTI M POGLIANI E INVERNIZZI R ALLIONE B MIRTO S SICA S LEONI F SELLERI C MANDELLI F
Citation: G. Meloni et al., INTERLEUKIN-2 THERAPY IN RELAPSED ACUTE MYELOGENOUS LEUKEMIA, The cancer journal from Scientific American, 3, 1997, pp. 43-47
USE OF TYPE-I AND TYPE-IV HYPERSENSITIVITY RESPONSES TO DEFINE THE IMMUNOPHARMACOLOGICAL PROFILE OF DRUGS
Authors: DIPIERRO F DATRI G MARCUCCI F LEONI F
Citation: F. Dipierro et al., USE OF TYPE-I AND TYPE-IV HYPERSENSITIVITY RESPONSES TO DEFINE THE IMMUNOPHARMACOLOGICAL PROFILE OF DRUGS, Journal of pharmacological and toxicological methods, 37(2), 1997, pp. 91-96
REPORT ON THE CONFERENCE ON MEDIEVAL TUSC ANY (11TH-CENTURY TO 14TH-CENTURY) HELD IN FLORENCE, NOVEMBER 29-30, 1996
Authors: LEONI F
Citation: F. Leoni, REPORT ON THE CONFERENCE ON MEDIEVAL TUSC ANY (11TH-CENTURY TO 14TH-CENTURY) HELD IN FLORENCE, NOVEMBER 29-30, 1996, Archivio storico italiano (Testo stampato), 155(572-73), 1997, pp. 523-526
A NEW RATIONAL HYPOTHESIS FOR THE PHARMACOPHORE OF THE ACTIVE METABOLITE OF LEFLUNOMIDE, A POTENT IMMUNOSUPPRESSIVE DRUG
Authors: BERTOLINI G AQUINO M BIFFI M DATRI G DIPIERRO F FERRARIO F MASCAGNI P SOMENZI F ZALIANI A LEONI F
Citation: G. Bertolini et al., A NEW RATIONAL HYPOTHESIS FOR THE PHARMACOPHORE OF THE ACTIVE METABOLITE OF LEFLUNOMIDE, A POTENT IMMUNOSUPPRESSIVE DRUG, Journal of medicinal chemistry, 40(13), 1997, pp. 2011-2016
EFFECT OF PARTIALLY MODIFIED RETRO-INVERSO ANALOGS DERIVED FROM C-REACTIVE PROTEIN ON THE INDUCTION OF NITRIC-OXIDE SYNTHESIS IN PERITONEAL-MACROPHAGES
Authors: ARCOLEO F MILANO S DAGOSTINO P MISIANO G CAPPELLETTI S GROMO G MARCUCCI F LEONI F CILLARI E
Citation: F. Arcoleo et al., EFFECT OF PARTIALLY MODIFIED RETRO-INVERSO ANALOGS DERIVED FROM C-REACTIVE PROTEIN ON THE INDUCTION OF NITRIC-OXIDE SYNTHESIS IN PERITONEAL-MACROPHAGES, British Journal of Pharmacology, 120(7), 1997, pp. 1383-1389
MOLECULAR REMISSION IN PML RAR-ALPHA-POSITIVE ACUTE PROMYELOCYTIC LEUKEMIA BY COMBINED ALL-TRANS-RETINOIC ACID AND IDARUBICIN (AIDA) THERAPY/
Authors: MANDELLI F DIVERIO D AVVISATI G LUCIANO A BARBUI T BERNASCONI C BROCCIA G CERRI R FALDA M FIORITONI G LEONI F LISO V PETTI MC RODEGHIERO F SAGLIO G VEGNA ML VISANI G JEHN U WILLEMZE R MUUS P PELICCI PG BIONDI A LOCOCO F
Citation: F. Mandelli et al., MOLECULAR REMISSION IN PML RAR-ALPHA-POSITIVE ACUTE PROMYELOCYTIC LEUKEMIA BY COMBINED ALL-TRANS-RETINOIC ACID AND IDARUBICIN (AIDA) THERAPY/, Blood, 90(3), 1997, pp. 1014-1021
FLUDARABINE, CYTARABINE AND G-CSF (FLAG) FOR THE TREATMENT OF HIGH-RISK MYELODYSPLASTIC SYNDROMES (MDS)
Authors: FERRARA F MIRTO S MONTILLO M MELE G TEDESCHI A CIOLLI S ANNUNZIATA M COPIA C MAGRIN S LEONI F
Citation: F. Ferrara et al., FLUDARABINE, CYTARABINE AND G-CSF (FLAG) FOR THE TREATMENT OF HIGH-RISK MYELODYSPLASTIC SYNDROMES (MDS), Blood, 90(10), 1997, pp. 371-371
A PHASE-I DOSE-FINDING STUDY OF PSC-833, A NOVEL MDR REVERSING AGENT,WITH MITOXANTRONE, ETOPOSIDE AND CYTARABINE (PSC-MEC) IN POOR-PROGNOSIS ACUTE-LEUKEMIA (AML)
Authors: VISANI G MILLIGAN D LEONI F CHANG J KELSEY S MARCUS R POWLES R SCHEY S COVELLI A
Citation: G. Visani et al., A PHASE-I DOSE-FINDING STUDY OF PSC-833, A NOVEL MDR REVERSING AGENT,WITH MITOXANTRONE, ETOPOSIDE AND CYTARABINE (PSC-MEC) IN POOR-PROGNOSIS ACUTE-LEUKEMIA (AML), Blood, 90(10), 1997, pp. 2518-2518
REPORT ON THE CONFERENCE ON FOODS AND NUT RITION FROM THE LATE-MIDDLE-AGES TO MODERN TIMES HELD IN PRATO, APRIL 22-27, 1996
Authors: LEONI F
Citation: F. Leoni, REPORT ON THE CONFERENCE ON FOODS AND NUT RITION FROM THE LATE-MIDDLE-AGES TO MODERN TIMES HELD IN PRATO, APRIL 22-27, 1996, Quaderni medievali, (42), 1996, pp. 191-200
HEMORRHAGIC CYSTITIS ASSOCIATED WITH BKV IN PATIENTS WITH REFRACTORY ACUTE LYMPHOBLASTIC-LEUKEMIA
Authors: AZZI A CIAPPI S DESANTIS R FANCI R LEONI F CIOLLI S ROSSIFERRINI PL
Citation: A. Azzi et al., HEMORRHAGIC CYSTITIS ASSOCIATED WITH BKV IN PATIENTS WITH REFRACTORY ACUTE LYMPHOBLASTIC-LEUKEMIA, American journal of hematology, 52(2), 1996, pp. 121-122
EXTRAMEDULLARY HEMATOPOIESIS IN THYROID MULTINODULAR GOITER PRECEDINGCLINICAL-EVIDENCE OF AGNOGENIC MYELOID METAPLASIA
Authors: LEONI F FABBRI R PASCARELLA A MARRANI C NOZZOLI C CIOLLI S MARCHETTI G FERRINI PR
Citation: F. Leoni et al., EXTRAMEDULLARY HEMATOPOIESIS IN THYROID MULTINODULAR GOITER PRECEDINGCLINICAL-EVIDENCE OF AGNOGENIC MYELOID METAPLASIA, Histopathology, 28(6), 1996, pp. 559-561
TREATMENT WITH MODIFIED HEPARINS INHIBITS EXPERIMENTAL METASTASIS FORMATION AND LEADS, IN SOME ANIMALS, TO LONG-TERM SURVIVAL
Authors: SCIUMBATA T CARETTO P PIROVANO P POZZI P CREMONESI P GALIMBERTI G LEONI F MARCUCCI F
Citation: T. Sciumbata et al., TREATMENT WITH MODIFIED HEPARINS INHIBITS EXPERIMENTAL METASTASIS FORMATION AND LEADS, IN SOME ANIMALS, TO LONG-TERM SURVIVAL, Invasion & metastasis, 16(3), 1996, pp. 132-143
LOW-DOSE CYTOSINE-ARABINOSIDE IN PATIENTS WITH ACUTE MYELOID-LEUKEMIANOT ELIGIBLE FOR STANDARD CHEMOTHERAPY
Authors: PASCARELLA A MARRANI C LEONI F CIOLLI S NOZZOLI C CAPORALE R SALTI F FERRINI PR
Citation: A. Pascarella et al., LOW-DOSE CYTOSINE-ARABINOSIDE IN PATIENTS WITH ACUTE MYELOID-LEUKEMIANOT ELIGIBLE FOR STANDARD CHEMOTHERAPY, Leukemia & lymphoma, 18(5-6), 1995, pp. 465-469
CHRONIC MYELOID-LEUKEMIA, BCR ABL TRANSCRIPT, RESPONSE TO ALPHA-INTERFERON AND SURVIVAL/
Authors: BACCARANI M TURA S RUSSO D BACCARANI M ZACCARIA A SAGLIO G GUERRASIO A MARTINELLI G ZUFFA E TESTONI N FARABEGOLI P ZAMAGNI MD FANIN R DAMIANI D DEMILIO A BATTISTA R SPECCHIA G LISO V DITUCCI A BROCCIA G MONTEFUSCO E MANDELLI F RAMBALDI A BARBUI T BODENIZZA CA CAROTENUTO M ROTONDO SG AMBROSETTI A PERONA G LUCIANO L ROTOLI B RONCO F NOBILE F TABILIO A LIBERATI A MARTELLI M GRIGNANI F PARDINI S LONGINOTTI M GENTILINI I COSER P LEONI F CIOLLI S MORRA E BERNASCONI C FERRERO D PILERI A LEONI P DANIELI G ABBADESSA A BRUZZESE L TRINGALI S CARONIA F GALIENI P DISPENSA E NOVARINO A CAPUCCI A IZZI T NOSARI A PIZZUTI M RICCIUTI F VASINO AC RESEGOTTI L CAPALDI A GIOVANNELLI E
Citation: M. Baccarani et al., CHRONIC MYELOID-LEUKEMIA, BCR ABL TRANSCRIPT, RESPONSE TO ALPHA-INTERFERON AND SURVIVAL/, Leukemia, 9(10), 1995, pp. 1648-1652
REPORT ON THE JUNE-16-18,1995 PISA CONFER ENCE ON MEDITERRANEAN COMMERCE IN THE MIDDLE-AGES
Authors: LEONI F
Citation: F. Leoni, REPORT ON THE JUNE-16-18,1995 PISA CONFER ENCE ON MEDITERRANEAN COMMERCE IN THE MIDDLE-AGES, Quaderni medievali, (40), 1995, pp. 249-257
AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION COMPARED WITH INTENSIVE CHEMOTHERAPY IN ACUTE MYELOGENOUS LEUKEMIA
Authors: ZITTOUN RA MANDELLI F WILLEMZE R DEWITTE T LABAR B RESEGOTTI L LEONI F DAMASIO E VISANI G PAPA G CARONIA F HAYAT M STRYCKMANS P ROTOLI B LEONI P PEETERMANS ME DARDENNE M VEGNA ML PETTI MC SOLBU G SUCIU S
Citation: Ra. Zittoun et al., AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION COMPARED WITH INTENSIVE CHEMOTHERAPY IN ACUTE MYELOGENOUS LEUKEMIA, The New England journal of medicine, 332(4), 1995, pp. 217-223
ATTENUATED-DOSE IDARUBICIN IN ACUTE MYELOID-LEUKEMIA OF THE ELDERLY -PHARMACOKINETIC STUDY AND CLINICAL-RESULTS
Authors: LEONI F CIOLLI S GIULIANI G PASCARELLA A CAPORALE R SALTI F CERVI L FERRINI PR
Citation: F. Leoni et al., ATTENUATED-DOSE IDARUBICIN IN ACUTE MYELOID-LEUKEMIA OF THE ELDERLY -PHARMACOKINETIC STUDY AND CLINICAL-RESULTS, British Journal of Haematology, 90(1), 1995, pp. 169-174
EXTRAMEDULLARY HEMATOPOIESIS IN THYROID MULTINODULAR GOITER PRECEDINGTHE CLINICAL-EVIDENCE OF AGNOGENIC MYELOID METAPLASIA
Authors: LEONI F FABBRI R PASCARELLA A MARRANI C NOZZOLI C CIOLLI S MARCHETTI G CAPORALE R FERRINI PR
Citation: F. Leoni et al., EXTRAMEDULLARY HEMATOPOIESIS IN THYROID MULTINODULAR GOITER PRECEDINGTHE CLINICAL-EVIDENCE OF AGNOGENIC MYELOID METAPLASIA, Blood, 86(10), 1995, pp. 3174-3174
ANTI-HIV TYPE-1 PROPERTIES OF CHEMICALLY-MODIFIED HEPARINS WITH DIMINISHED ANTICOAGULANT ACTIVITY
Authors: LOPALCO L CICCOMASCOLO F LANZA P ZOPPETTI G CARAMAZZA I LEONI F BERETTA A SICCARDI AG
Citation: L. Lopalco et al., ANTI-HIV TYPE-1 PROPERTIES OF CHEMICALLY-MODIFIED HEPARINS WITH DIMINISHED ANTICOAGULANT ACTIVITY, AIDS research and human retroviruses, 10(7), 1994, pp. 787-793
LEUKOCYTE SUBSETS AND CORTISOL SERUM LEVELS IN PATIENTS WITH MIGRAINEWITHOUT AURA AND CHRONIC TENSION-TYPE HEADACHE
Authors: LEONE M BIFFI M LEONI F BUSSONE G
Citation: M. Leone et al., LEUKOCYTE SUBSETS AND CORTISOL SERUM LEVELS IN PATIENTS WITH MIGRAINEWITHOUT AURA AND CHRONIC TENSION-TYPE HEADACHE, Cephalalgia, 14(2), 1994, pp. 139-142
INTERFERON ALFA-2A AS COMPARED WITH CONVENTIONAL CHEMOTHERAPY FOR THETREATMENT OF CHRONIC MYELOID LEUKEMIA
Authors: TURA S BACCARANI M ZUFFA E RUSSO D ZACCARIA A FIACCHINI M TESTONI N ZAMAGNI MD MARTINELLI G DAMIANI D MICHIELI M FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C ALIMENA G MANDELLI F LEONI P DANIELI G NOSARI A DECATALDO F MAJOLINO I CARONIA F LIBERATI AM GRIGNANI F TABILIO A MARTELLI M PAOLINO F RESEGOTTI L DITUCCI A BROCCIA G LEONI F CIOLLI S LUCIANO L ROTOLI B PERRICONE R CAJOZZO A MONTUORO A DELAURENZI A VOLPE E DEMILIO A BATTISTA R CAPUCCI A IZZI T SCAPOLI GL CASTOLDI GL LOMBARDO M TORLONTANO G LANDOLFI R LEONE G DELFINI C SPARAVENTI G PAPINESCHI F SPREMOLLA G RISSO M MARMONT AM DINI D DIPRISCO U MANGONI L RIZZOLI V GIRINO M ASCARI E BODENIZZA CA CAROTENUTO M DIFRANCESCO A QUAGLINO D NARDELLI S CICCONE F MIRAGLIA E DEBIASE R GALLO E PILERI A RAMBALDI A BARBUI T MORANDI S BIANCHINI E DEROSA C CIMINO R RONCA F NOBILE F CANTONETTI M PAPA G GALLAMINI A BUFFA F MUSOLINO C SQUADRITO G CAPALDI A GIOVANNELLI E PINOTTI G VENCO A ZAGONEL V PINTO A GENTILINI I COSER P GUGLIELMO P CACCIOLA E PIZZUTI M RICCIUTI F FANIN R CRISCUOLO D MONTEFUSCO E
Citation: S. Tura et al., INTERFERON ALFA-2A AS COMPARED WITH CONVENTIONAL CHEMOTHERAPY FOR THETREATMENT OF CHRONIC MYELOID LEUKEMIA, The New England journal of medicine, 330(12), 1994, pp. 820-825
THE MACROPHAGE-ACTIVATING TETRAPEPTIDE TUFTSIN INDUCES NITRIC-OXIDE SYNTHESIS AND STIMULATES MURINE MACROPHAGES TO KILL LEISHMANIA PARASITES IN-VITRO
Authors: CILLARI E ARCOLEO F DIELI M DAGOSTINO R GROMO G LEONI F MILANO S
Citation: E. Cillari et al., THE MACROPHAGE-ACTIVATING TETRAPEPTIDE TUFTSIN INDUCES NITRIC-OXIDE SYNTHESIS AND STIMULATES MURINE MACROPHAGES TO KILL LEISHMANIA PARASITES IN-VITRO, Infection and immunity, 62(6), 1994, pp. 2649-2652
INVOLVEMENT OF MULTIPLE PROTEIN-KINASES IN CD3-MEDIATED ACTIVATION OFHUMAN T-LYMPHOCYTES
Authors: CHIAFFARINO F BIFFI M LUCIANO A GROMO G LEONI F
Citation: F. Chiaffarino et al., INVOLVEMENT OF MULTIPLE PROTEIN-KINASES IN CD3-MEDIATED ACTIVATION OFHUMAN T-LYMPHOCYTES, Cellular immunology, 153(1), 1994, pp. 39-51
Risultati: 1-25 | 26-36